Robert Carey

CIK: 0001602064

Transaction Breakdown

Open Market Buys (P)3 (7.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)18 (46.2%)

Compensation grants

Other (G, F, J, C, D, …)18 (46.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

XAIR

Beyond Air, Inc.

Director

SGMO

SANGAMO THERAPEUTICS, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (39 total)

XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
10K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
10K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
4.5K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
4.5K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
2K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
2K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.5K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.5K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
50 shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
50 shares-
XAIR
Beyond Air, Inc.
Nov 3, 2025
Award(A)
Warrants to purchase Common Stock
Direct
494.3K shares-
XAIR
Beyond Air, Inc.
Nov 3, 2025
Disposition(D)
Warrants to purchase Common Stock
Direct
494.3K shares-
XAIR
Beyond Air, Inc.
Nov 3, 2025
Other(J)
Warrants to purchase Common Stock
Direct
512.8K shares-
SGMO
SANGAMO THERAPEUTICS, INC
Jun 12, 2025
Award(A)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Mar 26, 2025
Award(A)
Stock Options (Right to buy)
Direct
200K shares-
XAIR
Beyond Air, Inc.
Mar 14, 2025
Purchase(P)
Direct
10K shares at avg. $0.26$3K
XAIR
Beyond Air, Inc.
Mar 14, 2025
Purchase(P)
Direct
990K shares at avg. $0.25$248K
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
1K shares-

		Type	Shares	Price		Ownership
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	10,000	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	10,000	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	4,500	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	4,500	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	2,000	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	2,000	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,500	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,500	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	50	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	50	-	-	Direct
Nov 3, 2025	XAIR Beyond Air, Inc.	Award(A) Warrants to purchase Common Stock	494,332	-	-	Direct
Nov 3, 2025	XAIR Beyond Air, Inc.	Disposition(D) Warrants to purchase Common Stock	494,332	-	-	Direct
Nov 3, 2025	XAIR Beyond Air, Inc.	Other(J) Warrants to purchase Common Stock	512,821	-	-	Direct
Jun 12, 2025	SGMO SANGAMO THERAPEUTICS, INC	Award(A)	25,000	-	-	Direct
Mar 26, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	200,000	-	-	Direct
Mar 14, 2025	XAIR Beyond Air, Inc.	Purchase(P)	10,000	$0.26	$2,550	Direct
Mar 14, 2025	XAIR Beyond Air, Inc.	Purchase(P)	990,000	$0.25	$247,500	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	25,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,000	-	-	Direct

1-25 of 39 transactions

About Carey Robert

Carey Robert (SEC CIK 0001602064) files insider reports with the SEC as Director of Beyond Air, Inc. (XAIR) and Director of SANGAMO THERAPEUTICS, INC (SGMO).

Signal8 holds 7 ownership filings by Carey Robert, all Form 4s, filed between Oct 1, 2024 and Nov 7, 2025. Those filings report 39 transactions, from Sep 26, 2024 to Nov 4, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Carey Robert's filings is in GARDEN CITY, NY.

Recent filings by Carey Robert

Nov 4, 2025: Disposition to issuer transactions of XAIR derivative securities (2 lines, Form 4, code D).
Nov 4, 2025: Grants or awards of XAIR derivative securities (2 lines, Form 4, code A).
Nov 4, 2025: Disposition to issuer transaction of XAIR derivative securities (Form 4, code D).
Nov 4, 2025: Grant or award of XAIR derivative securities (Form 4, code A).
Nov 4, 2025: Disposition to issuer transaction of XAIR derivative securities (Form 4, code D).

Other insiders filing for Beyond Air, Inc. (XAIR)

Lin Yi-Chien, 10% Owner
MOORHEAD DANIEL J, Chief Financial Officer
Lee Yoori, Director
Gaul Michael A., Chief Operating Officer
Lucera Erick, Director
Larson Douglas Quinton, Chief Financial Officer

How to read Form 4 transaction codes